ARC-T Cells Plus SPRX002

Master Protocol for the Phase 1 Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome, Including Long-term Safety Follow-up

Near Add Your Location

Center of Excellence

City of Hope Comprehensive Cancer Center
Beckman Research Institute
Duarte, CA
  • Accepting patients

Center of Excellence

Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine
Baltimore, MD
  • Accepting patients

Center of Excellence

MD Anderson Cancer Center
The University of Texas
Houston, TX
  • Accepting patients

Center of Excellence

Dana-Farber Cancer Institute
Boston, MA
  • Accepting patients

Center of Excellence

Montefiore Medical Center
Bronx, NY
  • Not yet accepting
511 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.